Bharat Rasayan Ltd is engaged in the manufacturing of Technical Grade Pesticides and Intermediates used in the agro-chemical industry. Incorporated in 1989, the company operates as the flagship enterprise of the Bharat Group, which was established by visionary entrepreneur Sat Narain Gupta, a pioneer in the Indian agrochemicals industry since 1977. Bharat Rasayan Ltd. (BRL), as the Group's flagship company, was established as part of backward integration and is one of the largest manufacturers of technical grade pesticides in India. Known for its international quality and a broad portfolio encompassing insecticides, herbicides, fungicides, their formulations, and intermediates, BRL commands a strong customer base and is a government-recognized Star Export House.
The Company operates exclusively in the pesticides business segment. Its product categories include Insecticides, Herbicides, Fungicides, and Plant Growth Regulators. BRL holds a leading market position in many technical and intermediate products, such as Lambda Cyhalothrin Technical, Metaphenoxy Benzaldehyde, Metribuzine Technical, Thiamethoxam (Insecticides), and Fipronil (Insecticides). The company has also expanded its portfolio with new products like Fluxametamide, Tolfenpyrad Technical, and Diuron Technical. The top 10 products account for approximately 66% of total sales. This diversified product range allows Bharat Rasayan Ltd. to cater to a wide array of agricultural needs across different crops and seasons.
Currently, BRL operates two manufacturing plants located in Haryana and Dahej, Gujarat. The two units at Mokhra (near Rohtak) and Dahej have excelled in their targeted production. The manufacturing facility in Dahej was built on an initial investment of USD 30 million in 2012 and houses four manufacturing plants. Environmental, Health, and Safety (EHS) are integral to the manufacturing process, with BRL equipped with in-house systems for the treatment of solid, liquid, and gaseous effluents at these units.
The company is actively expanding its manufacturing capabilities with new facilities. A new greenfield third manufacturing facility, focusing on backward integration, is slated to commence production in December 2024. Additionally, BRL has a joint venture company, Nissan Bharat Rasayan Pvt Ltd, with Nissan Chemical Ltd., Japan, which will also start its manufacturing operations this month. This JV unit's primary focus will be the manufacturing of patented molecules for Nissan Chemical Ltd.'s global requirements.
With a dedicated team of scientists, Bharat Rasayan Ltd. holds over 195 international registrations and exports its products to more than 60 countries globally. BRL is a preferred supplier for several multinational corporations (MNCs) for their global demand of various molecules. The company has made significant inroads into key international markets, including the United States, with registrations for bifenthrin, lambdacyhalothrin, metribuzin, sulfosulfuron, and zeta cypermethrin. Furthermore, the company has expanded its presence in the Brazil market as per its strategy, registering bifenthrin, lambdacyhalothrin, and chlorpyriphos.
Bharat Rasayan Ltd. possesses a Government-approved R&D Centre and a pilot plant, focused on process excellence and supporting international registrations. The Bharat Group's R&D facilities have been recognized by the Government of India's Ministry of Science & Technology. This strong emphasis on research and development enables the company to continuously innovate and develop new products, effectively meeting evolving market demands.
- Market Capitalization: ₹4,807 Crore (as per recent data)
- Revenue: ₹306.53 Crore (as of March 2025 - Q4 FY25)
- Net Profit: ₹25.13 Crore (as of March 2025 - Q4 FY25)
The company has maintained a relatively stable financial position and is almost debt-free.
However, the company has faced some challenges in recent performance. Bharat Rasayan Ltd.'s net profit fell by -62.55% compared to the same period last year, amounting to ₹25.13 Crore in Q4 2024-2025. The company has shown poor sales growth of -0.67% over the past five years. Despite these challenges, the company has a low return on equity of 12.0% over the last 3 years.
Bharat Rasayan Ltd. informed BSE that the Board of Directors, at its meeting held on May 28, 2025, recommended a final dividend of 15%, i.e., ₹1.50 per share on the fully paid-up equity shares of ₹10/- each for the financial year ended March 31, 2025. This final dividend will be payable after its approval by the shareholders in the forthcoming Annual General Meeting.
All of Bharat Rasayan's Group companies are ISO 9001:2008 and ISO 14001:2004 certified. Each manufacturing unit is equipped with an analytical laboratory to ensure a high degree of quality in its products. The company maintains strict quality control measures and environmental standards across all its manufacturing facilities.
Mr. Sat Narain Gupta, the founder of Bharat Group, is also the Chairman and Managing Director of Bharat Rasayan Limited. With almost four decades of experience in the manufacture and trade of pesticides, Mr. Gupta is highly respected in the industry for his acumen. A postgraduate in Economics, his areas of specialization include International Business, Overall Marketing Strategy, and Corporate Planning.
The company operates under experienced leadership with a focus on sustainable growth and international expansion. The Promoter Holding of 75.0% indicates strong promoter confidence in the company's future prospects.
The agrochemicals industry continues to face challenges from global market conditions, but Bharat Rasayan's established manufacturing capabilities, international presence, and focus on backward integration position it to capitalize on future opportunities in the growing agricultural sector.
